secwatch.observer — SEC 8-K summary
======================================

Issuer:     FILANA THERAPEUTICS, INC. (FLNA)
CIK:        0001069530
Form:       8-K
Filed at:   2024-01-03T23:59:59+00:00
Accession:  0001493152-24-000209
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cassava Sciences distributes warrants to common shareholders; each 10 shares get 4 warrants exercisable at $33
--------------------------------------------------------------------------------

- Distribution of warrants to holders of record as of Dec 22, 2023, at ratio of 4 warrants per 10 common shares.
- Each warrant allows purchase of one share at $33, plus a bonus of 0.5 additional shares if exercised before bonus expiry.
- Warrants expire Nov 15, 2024; redeemable by company after Apr 15, 2024 at 1/10 of $0.01 per warrant.
- Warrants expected to trade on Nasdaq under ticker SAVAW starting Jan 4, 2024.
- Prospectus supplement filed to register 24,342,150 shares of common stock for issuance upon warrant exercise.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1069530/000149315224000209/0001493152-24-000209-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1069530/000149315224000209/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-000209

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer